Get started
EXACT SCIEN. DL-,01EXACT SCIEN. DL-,01EXACT SCIEN. DL-,01

EXACT SCIEN. DL-,01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals Bonds

EXK chart


Full chart

EXK upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.89 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.055 EUR
Net income (FY)
‪−184.96 M‬ EUR
Revenue (FY)
‪2.26 B‬ EUR
Shares float
‪182.28 M‬
Beta (1Y)
−0.33

About Exact Sciences Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Kevin T. Conroy
Website
exactsciences.com
Headquarters
Madison
Founded
1995
FIGI
BBG000CNDFN2
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

EXK news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

EXK highest yielding bonds


EXAS4806408
Exact Sciences Corporation 0.375% 15-MAR-2027
Yield to maturity
5.98%
Maturity date
Mar 15, 2027
EXAS4957195
Exact Sciences Corporation 0.375% 01-MAR-2028
Yield to maturity
5.14%
Maturity date
Mar 1, 2028
EXAS5793007
Exact Sciences Corporation 1.75% 15-APR-2031
Yield to maturity
3.72%
Maturity date
Apr 15, 2031
EXAS5549793
Exact Sciences Corporation 2.0% 01-MAR-2030
Yield to maturity
2.66%
Maturity date
Mar 1, 2030
EXAS4586328
Exact Sciences Corporation 1.0% 15-JAN-2025
Yield to maturity
1.76%
Maturity date
Jan 15, 2025

Explore more bonds 

Sparks


Curated watchlists where EXK is featured.

See all sparks 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange EXACT SCIEN. DL-,01 stocks are traded under the ticker EXK.
We've gathered analysts' opinions on EXACT SCIEN. DL-,01 future price: according to them, EXK price has a max estimate of 79.30 EUR and a min estimate of 55.98 EUR. Watch EXK chart and read a more detailed EXACT SCIEN. DL-,01 stock forecast: see what analysts think of EXACT SCIEN. DL-,01 and suggest that you do with its stocks.
EXK reached its all-time high on Feb 15, 2021 with the price of 129.460 EUR, and its all-time low was 0.220 EUR and was reached on Dec 17, 2008. View more price dynamics on EXK chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track EXACT SCIEN. DL-,01 financials in yearly and quarterly reports right on TradingView.
EXACT SCIEN. DL-,01 is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
EXK earnings for the last quarter are −0.19 EUR per share, whereas the estimation was −0.18 EUR resulting in a −7.20% surprise. The estimated earnings for the next quarter are −0.32 EUR per share. See more details about EXACT SCIEN. DL-,01 earnings.
EXACT SCIEN. DL-,01 revenue for the last quarter amounts to ‪636.47 M‬ EUR, despite the estimated figure of ‪643.79 M‬ EUR. In the next quarter, revenue is expected to reach ‪659.96 M‬ EUR.
EXK net income for the last quarter is ‪−34.34 M‬ EUR, while the quarter before that showed ‪−14.76 M‬ EUR of net income which accounts for −132.69% change. Track more EXACT SCIEN. DL-,01 financial stats to get the full picture.
No, EXK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 15, 2024, the company has ‪6.60 K‬ employees. See our rating of the largest employees — is EXACT SCIEN. DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXACT SCIEN. DL-,01 EBITDA is ‪−19.72 M‬ EUR, and current EBITDA margin is −3.05%. See more stats in EXACT SCIEN. DL-,01 financial statements.
Like other stocks, EXK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXACT SCIEN. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.